September 19, 2022
RFA-HL-23-015 - New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed)
RFA-HL-23-016 - New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute (NHLBI)
National Human Genome Research Institute (NHGRI)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Minority Health and Health Disparities (NIMHD)
The purpose of this Notice is to inform potential applicants that NHLBI has provided additional information regarding the allocation of our collaborating ICs' funding contribution to the total budget for RFA-HL-23-015 "(New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3)".
Section II. Award Information in RFA-HL-23-015 has been modified, as follows:
Part 2. Full Text of Announcement
Section II. Award Information
Funds Available and Anticipated Number of Awards
Current Language:
The following NIH components intend to commit the following amounts:
NHLBI intends to fund 4 to 6 awards, corresponding to total costs of up to $2.3 million in Fiscal Year (FY) 2023, $2.4 million in FY2024, $2.5 million per year in FY2025, FY2026 and FY2027, and $2.1 million in FY2028 and FY2029 for a total contribution of $16.4 million for 7 years. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
NIMHD, NINDS, and NHGRI each intend to commit individually $500,000 per year for FY 2023-2029 to co-fund applications in response to RFA-HL-23-015 and RFA-HL-23-016. Other NIH Institutes/Centers who are interested in collaborating will have an opportunity to join at a later time.
Together, NHLBI and collaborating NIH ICs intend to commit an estimated total of $16.4 million from NHLBI for RFA-HL-23-015 and up to $10.5 million from collaborating ICs across RFA-HL-23-015 and RFA-HL-23-016 to fund 4-6 awards for the entire 7 years period.
NIMH intends to commit up to $500,000 per year for FY 2023-2029 to co-fund applications in response to RFA-HL-23-015 and RFA-HL-23-016.
Awards issued under this FOA are contingent upon the availability of funds.
Modified to Read (changes shown in bold italics):
The following NIH components intend to commit the following amounts:
NHLBI intends to commit total costs of up to $2.3 million in Fiscal Year (FY) 2023, $2.4 million in FY2024, $2.5 million per year in FY2025, FY2026 and FY2027, and $2.1 million in FY2028 and FY2029 for a total contribution of up to $16.4 million.
NIMHD, NINDS, NHGRI, and NIMH each intend to commit individually $500,000 per year for FY 2023-2029 to co-fund applications in response to RFA-HL-23-015 and RFA-HL-23-016. Other NIH Institutes/Centers who are interested in collaborating will have an opportunity to join at a later time.
Together, NHLBI and collaborating NIH ICs intend to commit an estimated total of $20.5 million to fund 4-6 awards for the entire 7 years period. The total intended committed amount for the UG3/UH3 budget are up to $2.9M in FY2023, $3.0M in FY2024, $3.1M in FY2025, $3.1M in FY2026, $3.1M in FY2027, $2.6M in FY2028, and $2.6M in FY2029.
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
All other aspects of the FOA remain the same.
and Human Services (HHS)
